Mental Health & Psychiatry Clinical Trials Update: Week 25, 2026
Published June 19, 2026 — 5 trials covered
By Victor Lafforgue, Founder of TrialsAlert. Blog posts are AI-drafted from ClinicalTrials.gov source data and reviewed by the editorial team. See our editorial policy for details.
EEG Biomarkers for ADHD Stimulant Treatment
This Phase 4 trial led by Boston Children’s Hospital is exploring whether brain activity patterns measured by EEG can help predict which stimulant medication works best for children with ADHD. The study focuses on children ages 7 to 11 and aims to personalize treatment, potentially reducing the trial-and-error process that many families face. If successful, this approach could help manage symptoms more effectively and improve daily life for children with ADHD.
Mobile Health and COVID-19
Conducted by the University of Houston, this study tested a mobile health app designed to support adults dealing with anxiety and depression during the COVID-19 pandemic. The app monitors COVID-19 risks while offering mental health support, aiming to provide an accessible tool that could help users manage symptoms more easily. The study has been completed with results available, highlighting a promising way to address mental health challenges using technology.
Photography-Based Intervention for Children With Attention Deficit Hyperactivity Disorder
This trial from The Hong Kong Polytechnic University is investigating a creative approach to help children with ADHD by using photography as a behavioral intervention. The goal is to improve emotional recognition and reduce symptoms by engaging children in activities that help them better understand and express their feelings. This simple and engaging tool could support social skills development and overall well-being in children with ADHD.
Our Voices Matter: Intervention for Depression in Youth
Ann & Robert H Lurie Children’s Hospital of Chicago is conducting a study focusing on Black and Latinx youth that combines behavioral intervention with racial justice activism. The trial aims to reduce depression and related health risks by addressing the impact of structural racism on mental and physical health. Participants will be followed for two years, offering new insights into how community and activism may support young people’s well-being.
Facial Affect Sensitivity Training for Young Children With Callous-unemotional Traits
This University of Alabama study tested a training program designed to help young children with callous-unemotional traits recognize and respond to facial emotions. The intervention aims to improve empathy and emotional understanding, which could reduce behaviors linked to conduct problems. Results are pending, but this approach could offer a new way to support children facing these challenges.
TrialsAlert subscribers received the full impact-classified briefing and doctor-ready report this week. Get weekly briefings at trialsalert.com.